| Patients (N = 1048) | ||||||
---|---|---|---|---|---|---|---|
Total (n = 1048) | Endometrioid Adenocarcinoma (n = 973) | Nonendometrioid Carcinoma (n = 75) | p-value | ||||
Clinical Characteristic | No. | % | No. | %b | No. | %b | Â |
Age, years | Â | Â | Â | Â | Â | Â | 0.129 |
 Mean | 56.1 |  | 56.0 |  | 57.6 |  |  |
 Range | 23–86 |  | 23–86 |  | 33–79 |  |  |
Lymphadenectomy | Â | Â | Â | Â | Â | Â | 0.010 |
 No | 319 | 30.4 | 306 | 31.4 | 13 | 17.3 |  |
 Yes | 729 | 69.6 | 667 | 68.6 | 62 | 82.7 |  |
 Median Number. | 21.0 |  | 21.0 |  | 18.0 |  | 0.009 |
 Range | 1–65 |  | 1–65 |  | 1–42 |  |  |
Stage (FIGO 2009) | Â | Â | Â | Â | Â | Â | 0.012 |
 IA | 474 | 45.2 | 428 | 44.0 | 46 | 61.3 |  |
 IB | 426 | 40.7 | 406 | 41.7 | 20 | 26.7 |  |
 II | 148 | 14.1 | 139 | 14.3 | 9 | 12.0 |  |
Diameter | Â | Â | Â | Â | Â | Â | 0.630 |
  < 2 cm | 111 | 10.6 | 102 | 16.1 | 9 | 18.8 |  |
  ≥ 2 cm | 571 | 54.5 | 532 | 83.9 | 39 | 81.3 |  |
 Missing | 366 | 34.9 |  |  |  |  |  |
Gradea | |||||||
 G1 | 327 | 33.6 | 327 | 33.6 | / | / |  |
 G2 | 447 | 45.9 | 447 | 45.9 | / | / |  |
 G3 | 191 | 19.7 | 191 | 19.7 | / | / |  |
 Missing | 8 | 0.8 | 8 | 0.8 | / | / |  |
Myometrial invasion | Â | Â | Â | Â | Â | Â | 0.012 |
  < 1/2 | 535 | 51.0 | 486 | 50.4 | 49 | 65.3 |  |
  ≥ 1/2 | 505 | 48.2 | 479 | 49.6 | 26 | 34.7 |  |
 Missing | 8 | 0.8 |  |  |  |  |  |
Invasion of lower uterine segment | Â | Â | Â | Â | Â | Â | 0.080 |
 No | 746 | 71.2 | 686 | 70.5 | 60 | 80.0 |  |
 Yes | 302 | 28.8 | 287 | 29.5 | 15 | 20.0 |  |
LVSI | Â | Â | Â | Â | Â | Â | 0.601 |
 Present | 173 | 16.5 | 159 | 16.3 | 14 | 18.7 |  |
 Absent | 875 | 83.5 | 814 | 83.7 | 61 | 81.3 |  |
Chemotherapy | Â | Â | Â | Â | Â | Â | 0.000 |
 No | 820 | 78.2 | 786 | 80.8 | 34 | 45.3 |  |
 Yes | 228 | 21.8 | 187 | 19.2 | 41 | 54.7 |  |